Varicella-Zoster Virus Vaccine News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Study Suggests Link Between Untreated Depression And Response To Shingles Vaccine
Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition caused by the reactivation of the varicella-zoster virus, and more than a million new cases occur each year in the U.S. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 14, 2013 Category: Consumer Health News Tags: Depression Source Type: news

Study suggests link between untreated depression and response to shingles vaccine
(Infectious Diseases Society of America) Results from a new study published in Clinical Infectious Diseases suggest a link between untreated depression in older adults and decreased effectiveness of the herpes zoster, or shingles, vaccine. Older adults are known to be at risk for shingles, a painful condition caused by the reactivation of the varicella-zoster virus, and more than a million new cases occur each year in the US. The vaccine boosts cell-mediated immunity to the virus and can decrease the incidence and severity of the condition. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 14, 2013 Category: Global & Universal Source Type: news

Merck Announces Full-Year and Fourth-Quarter 2012 Financial Results
Dateline City: WHITEHOUSE STATION, N.J. 2012 Full-Year Non-GAAP EPS of $3.82, Excluding Certain Items; GAAP EPS of $2.16; Fourth-Quarter Non-GAAP EPS of $0.83, Excluding Certain Items; GAAP EPS of $0.46 2012 Full-Year Worldwide Sales Were $47.3 Billion, a Decrease of 2 Percent, Including a 3 Percent Unfavorable Impact from Foreign Exchange; Fourth-Quarter Worldwide Sales Were $11.7 Billion, a Decline of 5 Percent, Including a 2 Percent Unfavorable Impact...
Source: Merck.com - Corporate News - February 1, 2013 Category: Pharmaceuticals Authors: hq_site_admin Tags: Corporate News Financial News Source Type: news

UK First Major European Country To Run Zostavax Nationwide Shingles Vaccination Programme
Vaccine to be given to UK seniors to help protect against shingles The UK has decided to launch the first-ever national shingles immunisation campaign in Europe using the innovative Zostavax vaccine from Sanofi Pasteur MSD, the joint venture in Europe between MSD and Sanofi Pasteur. Eligible senior members of the public will be able to receive the Zostavax vaccine during regular health visits or at the same time as their seasonal flu jab. The decision from the UK's Department of Health follows a comprehensive assessment of the health and economic benefits of shingles vaccination... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 24, 2013 Category: Consumer Health News Tags: Immune System / Vaccines Source Type: news